Bigul

Q3FY22 Quarterly Result Announced for Jyothy Labs Ltd.

Personal Products company Jyothy Labs declares Q3FY22 result: Net Sales at Rs. 539 Crores, up by 13.1%. 2 year CAGR growth of 13.2% EBITDA at Rs. 61.2 Crores (11.3% to net sales) Crores versus Rs 79.8 Crores (16.7% to net sales) Net Profit at Rs 38 Crores versus Rs. 53.2 Crores Commenting on the financial performance of Q3FY2022, Ms. M R Jyothy, Managing Director, Jyothy Labs Limited said “ We have been consistently delivering double digit growth for last few quarters backed by our relentless focus on execution to build scale with agility which has resulted in market share gains across categories. This has been achieved inspite of challenging higher input price environment resulting into increase in retail prices which impacts consumers purchasing power. While we continue to face margin pressure, we will focus on our strategic levers to offer better value proposition to consumers and focus on distribution which will aid in accelerating us towards higher revenue growth’’ Result PDF
21-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Change in Directorate

This is to inform that Mr. Kasaragod Ullas Kamath [DIN: 00506681] will cease to be the Joint Managing Director, member of the Board of Directors and its Committees thereof with effect from the closing hours of January 22, 2022
21-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Results- Financial Results For Quarter And Nine Months Ended December 31, 2021

The Board of Directors of the Company approved the Un-audited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2021 with Limited Review by the Statutory Auditors of the Company
21-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Conference Call for analyst/ investors under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
14-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Conference Call for analyst/ investors under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
14-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
13-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Friday, January 21, 2022

Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2022 ,inter alia, to consider and approve Board Meeting to consider and approve the Unaudited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31, 2021, with limited review thereon by the Statutory Auditors of the Company
12-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2021
11-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Shareholding for the Period Ended December 31, 2021

Jyothy Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
07-01-2022
Bigul

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
03-01-2022
Next Page
Close

Let's Open Free Demat Account